Ignite Creation Date:
2024-07-17 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06492304
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-21
Brief Title:
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With RelapsedRefractory Hematologic Malignancies
Sponsor:
CRISPR Therapeutics
Organization:
CRISPR Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2030-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-11
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-21
First Submit QC Date:
None
Study First Post Date:
2024-07-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-26
Last Update Post Date:
2024-07-09
Last Update Post Date Type:
ACTUAL